Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis

被引:1
|
作者
Giannini, M. [1 ,2 ]
Grignaschi, S. [3 ,4 ,5 ]
Fornaro, M. [1 ]
Caporali, R. [6 ]
Locatelli, F. [3 ,4 ,5 ]
Zanframundo, G. [3 ,4 ,5 ]
Meyer, A. [2 ,5 ,7 ]
Montecucco, C. [3 ,4 ,5 ]
Iannone, F. [1 ]
Paolino, S. [8 ,9 ]
Cavagna, L. [3 ,4 ,5 ]
机构
[1] Univ Bari, Rheumatol Unit DETO, Bari, Italy
[2] Hop Univ Strasbourg, Serv Physiol, Unite Explorat Fonct Musculaires, Strasbourg, France
[3] Univ Pavia, Rheumatol Div, Viale Camillo Golgi 19, I-27100 Pavia, Italy
[4] IRCCS Policlin S Matteo Fdn, Viale Camillo Golgi 19, I-27100 Pavia, Italy
[5] European Reference Network ReCONNET, Milan, Italy
[6] Univ Milan, Hosp G Pini CTO, Rheumatol Div, Milan, Italy
[7] Hop Univ Strasbourg, Serv Rhumatol, Ctr Natl Reference Malad Syst & Autoimmunes Rares, Strasbourg, France
[8] Univ Genoa, Res Lab, Dept Internal Med, Genoa, Italy
[9] Univ Genoa, Acad Div Clin Rheumatol, Dept Internal Med, Genoa, Italy
关键词
thrombocytopenia; idiopathic inflammatory myopathies; myositis specific antibodies; myositis-associated antibodies; INTERSTITIAL LUNG-DISEASE; CELL ACTIVATING FACTOR; THROMBOTIC MICROANGIOPATHY; IMMUNE THROMBOCYTOPENIA; DERMATOMYOSITIS; PATIENT; MORTALITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic inflammatory myopathies (IIMs) are a group of rare connective tissue diseases (CTDs) deeply affecting patients' prognosis. Extra-muscular involvement is not rare and skin, joints and lung are the most common targets. However, also dyserythropoiesis has been described, carrying relevant issues on patients' management and follow-up, as for example, lymphopenia has been associated with an increased risk of rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis. Conversely to systemic lupus erythematosus, thrombocytopenia has only been rarely described in IIMs and very few authors have focused on its potential prognostic implications. We describe five cases of thrombocytopenia in IIMs patients positive for myositis specific (MSA) or associated (MAA) autoantibodies. These reports extend the spectrum of haematological features associated to IIMs, focusing also on potential risk factors for thrombocytopenia occurrence.y
引用
收藏
页码:891 / 895
页数:5
相关论文
共 50 条
  • [31] Juvenile Idiopathic Inflammatory Myopathies
    Huber, Adam M.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2018, 65 (04) : 739 - +
  • [32] Relapses in idiopathic inflammatory myopathies
    Miró, O
    Laguno, M
    Grau, JM
    MUSCLE & NERVE, 1999, 22 (08) : 1159 - 1160
  • [33] Idiopathic inflammatory myopathies - myositis
    Dorph, C
    Lundberg, IE
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (05): : 817 - 832
  • [34] Cytokines in idiopathic inflammatory myopathies
    Salomonsson, Stina
    Lundberg, Ingrid E.
    AUTOIMMUNITY, 2006, 39 (03) : 177 - 190
  • [35] Idiopathic Inflammatory Myopathies and Malignancy
    Elizabeth Hendren
    Ophir Vinik
    Current Treatment Options in Rheumatology, 2017, 3 (4) : 299 - 307
  • [36] PATHOGENESIS OF IDIOPATHIC INFLAMMATORY MYOPATHIES
    Nagaraju, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 21 - 21
  • [37] History of Idiopathic Inflammatory Myopathies
    Reimers, Carl D.
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (05) : 424 - 431
  • [38] Treatment of idiopathic inflammatory myopathies
    Amato, AA
    Griggs, RC
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (05) : 569 - 575
  • [39] Immunopathogenesis of the idiopathic inflammatory myopathies
    De Bleecker, J
    ACTA NEUROPATHOLOGICA, 2002, 104 (05) : 548 - 548
  • [40] Registries in idiopathic inflammatory myopathies
    Lundberg, Ingrid E.
    Svensson, John
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (06) : 729 - 734